Pharmafile Logo

Social distancing

- PMLiVE

Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%

Bamlanivimab-treated care home residents and staff had a significant reduction in COVID-19 risk

- PMLiVE

Pfizer/BioNTech’s COVID-19 vaccine found to be effective against UK virus variant

BioNTech is planning to publish analysis on vaccine's efficacy against South African variant

- PMLiVE

The pandemic preparedness paradox

Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity

- PMLiVE

Trial combining British and Russian COVID-19 vaccines could begin in February

AstraZeneca announced the clinical trial programme in December

- PMLiVE

Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions

Possible adverse events reported at a vaccination centre in the US

EU flag

EU proposes vaccine-sharing mechanism with low-income countries

Mechanism could provide low-income countries with early access to COVID-19 vaccines

- PMLiVE

WHO’s director-general deems vaccine nationalism a “catastrophic moral failure”

Tedros Adhanom Ghebreyesus warns bilateral deals could threaten COVAX facility

- PMLiVE

NHS is set to begin offering COVID-19 vaccinations to over-70s this week

Announcement comes as ten new vaccination centres open in England

- PMLiVE

Cambridge University develops DNA test for secondary infections in COVID-19 patients

Test can identify cases of ‘ventilator-associated pneumonia’

- PMLiVE

Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU

'Temporary' reduction comes as companies bolster production capacity for the year

- PMLiVE

The search for effective drug treatments for COVID-19

PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links